Is the platelet lowering activity of anagrelide mediated by its major metabolite 2-amino-5,6-dichloro-3,4-dihydroquinazoline (RL603)?

Jorge D. Erusalimsky; Ying Hong; Richard Franklin

doi:10.1016/S0301-472X(02)00870-6

Is the platelet lowering activity of anagrelide mediated by its major metabolite 2-amino-5,6-dichloro-3,4-dihydroquinazoline (RL603)?

Jorge D. Erusalimsky
, Ying Hong
, Richard Franklin

Research output: Contribution to journal › Letter › peer-review

15 Citations (Scopus)

Original language	English
Pages (from-to)	625-626
Number of pages	2
Journal	Experimental Hematology
Volume	30
Issue number	7
DOIs	https://doi.org/10.1016/S0301-472X(02)00870-6
Publication status	Published - 2002
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S0301-472X(02)00870-6

Cite this

@article{4ca2b5b656904443bf87c9630fb82ed1,

title = "Is the platelet lowering activity of anagrelide mediated by its major metabolite 2-amino-5,6-dichloro-3,4-dihydroquinazoline (RL603)?",

author = "Erusalimsky, \{Jorge D.\} and Ying Hong and Richard Franklin",

year = "2002",

doi = "10.1016/S0301-472X(02)00870-6",

language = "English",

volume = "30",

pages = "625--626",

journal = "Experimental Hematology",